A new deep-learning AI algorithm significantly lowered false positives in lung nodule malignancy assessment while maintaining high detection rates.
Key Details
- 1Deep-learning algorithm estimated lung nodule malignancy risk using LDCT data.
- 2Trained on 16,077 nodules (1,249 malignant) from the NLST; validated on a pooled cohort of 4,146 participants and 7,794 nodules.
- 3AUC for AI model was equal or superior to PanCan: ~0.98 (1yr), 0.96 (2yr) in pooled cohort; up to 0.95 for indeterminate nodules.
- 4For size-matched nodules, AI model AUC was 0.79 vs. PanCan at 0.6.
- 5At 100% sensitivity for cancer, AI flagged 68.1% of benign nodules as low-risk vs. PanCan's 47.4% (39.4% relative reduction in false positives).
- 6Authors stress the need for prospective clinical validation before routine use.
Why It Matters
Reducing false positives in lung cancer screening can minimize unnecessary procedures, patient anxiety, and healthcare costs. Improved AI-based risk stratification stands to improve the efficiency and effectiveness of LDCT lung cancer screening programs.
Source
AuntMinnie
Related News
•HealthExec
AI's Expanding Role in Healthcare and Implications for Radiology
A series of thought leaders and institutions weigh in on AI's transformative potential in healthcare, with emphasis on radiology adoption and responsible use.
•Radiology Business
Most Radiology AI Users Lack Clear Evidence of Financial ROI
Survey finds over 75% of radiology organizations using AI lack clear, quantified ROI data.
•AuntMinnie
Paul Chang Discusses Foundation Models and Agentic AI at RSNA 2025
Dr. Paul Chang shares his insights on the role of foundation models and agentic AI in radiology at RSNA 2025.